P-53 Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Outcomes from the phase 3 CHAMPION-NMOSD trial. (April 2023)

Record Type:
Journal Article
Title:
P-53 Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Outcomes from the phase 3 CHAMPION-NMOSD trial. (April 2023)
Main Title:
P-53 Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Outcomes from the phase 3 CHAMPION-NMOSD trial
Authors:
Pittock, S.
Barnett, M.
Bennett, J.L.
Berthele, A.
de Sèze, J.
Levy, M.
Nakashima, I.
Oreja-Guevara, C.
Palace, J.
Paul, F.
Pozzilli, C.
Allen, K.
Mashhoon, Y.
Yountz, M.
Kim, H.J.
Abstract:
Is Part Of:
Clinical neurophysiology. Volume 148(2023)
Journal:
Clinical neurophysiology
Issue:
Volume 148(2023)
Issue Display:
Volume 148, Issue 2023 (2023)
Year:
2023
Volume:
148
Issue:
2023
Issue Sort Value:
2023-0148-2023-0000
Page Start:
e32
Page End:
Publication Date:
2023-04
Subjects:
Neurophysiology -- Periodicals
Electroencephalography -- Periodicals
Electromyography -- Periodicals
Neurology -- Periodicals
612.8
Journal URLs:
http://www.sciencedirect.com/science/journal/13882457 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.clinph.2023.02.070 ↗
Languages:
English
ISSNs:
1388-2457
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3286.310645
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
26080.xml